Patent ID: 9493403
Filing Date: 2016-11-15
CPC Classification: A61K,A61P,C07C

Claim Text:
1. A method of treating an androgen decline in aging male (ADAM)-associated condition in a male subject, wherein said ADAM-associated condition is selected from the group consisting of fatigue, depression, decreased libido, sexual dysfunction, erectile dysfunction, hypogonadism, osteoporosis, hair loss, anemia, obesity, sarcopenia, osteopenia, benign prostate hyperplasia, alterations in mood and cognition, said method comprising the step of administering to said subject a selective androgen receptor modulator (SARM) compound represented by the structure of formula V: wherein R R R is alkyl, haloalkyl, dihaloalkyl, trihaloalkyl, CH Z is NO Y is CF Q is alkyl, F, Cl, Br, I, CF n is an integer of 1-4; and m is an integer of 1-3, or its optical isomer or pharmaceutically acceptable salt, or any combination thereof.